Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Around the web

Radiologists need better access to patient data stored in the electronic medical record, imaging IT expert Rik Primo explains. 

Imaging IT expert Rik Primo discusses emerging issues he saw at RSNA and HIMSS.

Many new imaging solutions were on display at the world's largest health informatics conference, held at McCormick Place in Chicago.

artificial intelligence healthcare industry digest

ChatGPT knows a lot about PET scans, but its advice is inconsistent

The popular AI chatbot got most of the answers it was asked by researchers right, but its reliability is still up in the air.

September 15, 2023

Experts advocate for more intensive head-and-neck cancer follow-up using FDG-PET/CT

Scientists believe this is the first series demonstrating a significant survival difference in patients monitored with an intensive follow-up strategy via 18F-fludeoxyglucose–positron emission tomography.  

August 11, 2023

Tau PET the best tool to predict rate of cognitive decline in Alzheimer’s

Given the approach’s “superior prognostic value,” experts urged for the incorporation of tau PET into routine clinical evaluation in memory care clinics. 

August 11, 2023
molecular imaging study on brain connections in obese individuals

Obesity linked to altered brain connectivity on PET/MRI exams

New research, presented at SNMMI 2023, details how the brains of obese individuals differ from those who maintain a healthy weight.  

June 27, 2023
SNMMI Image of the Year

SNMMI unveils Image of the Year

This year the Henry N. Wagner Jr., Image of the Year is actually a group of images displaying the efficacy of a 68Ga-DOTA-5G and 177Lu-DOTA-ABM-5G theranostic pairing that improves the detection and treatment of metastatic pancreatic cancer. 

June 26, 2023
whole-body pet scanner add-on device presented at #SNMMI 2023

New PET technology offers 'clear improvement' of whole-body scan resolution

The new technology achieves this by way of two add-on detectors that simultaneously scan patients during their whole-body PET exam.

June 26, 2023
Prostate Cancer

New prostate cancer PET imaging agent officially available for commercial use

Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.

June 21, 2023
folate-based radiopharmaceuticals

Folate-based radiopharmaceuticals could improve detection of gliomas

According to new research, gliomas—a deadly group of brain tumors that are difficult to treat—have increased folate receptor expression, meaning they also show increased uptake of folate-based radiopharmaceuticals on PET imaging.

June 15, 2023
Trimed Popup
Trimed Popup